Helicobacter pylori – Therapy and Use of Medicinal Plants

*Helicobacter pylori* is a gram-negative, helical-shaped bacterium whose primary ecological niche is the human gastrointestinal tract. While initial references to this microorganism emerged in late 19th-century medical literature, its direct isolation from the gastric mucosa of patients with ulcerative lesions was not achieved until 1982, thanks to the groundbreaking research conducted by Barry Marshall and Robin Warren. Contemporary epidemiological estimates suggest that *H. pylori* colonizes the digestive systems of up to 50% of the global population, though only 10–20% of infected individuals develop symptomatic conditions attributable to its presence. The highest prevalence rates are documented in low-income regions where suboptimal sanitary conditions and personal hygiene practices prevail. Transmission occurs predominantly via fecal–oral or oral–oral routes, frequently during early childhood. Owing to its capacity to secrete urease, *H. pylori* effectively neutralizes the acidic gastric environment, thereby facilitating its survival and proliferation within the mucus layer overlaying the gastric epithelium. Initially, the bacterium colonizes the pyloric antrum—the anatomical junction between the esophagus and stomach—before progressively spreading across the entire mucosal surface and occasionally reaching the proximal duodenum. Chronic infection with this pathogen constitutes the primary risk factor for the development of type B gastritis, peptic ulcer disease (affecting both the stomach and duodenum), and—over prolonged periods—gastric adenocarcinoma and mucosa-associated lymphoid tissue (MALT) lymphoma.

Therapeutic intervention should be initiated exclusively following a definitive diagnostic confirmation of Helicobacter pylori infection. The established clinical gold standard consists of quadruple eradication therapy combining potent gastric acid suppression (proton pump inhibitors, PPIs) with targeted antibiotics and bismuth subcitrate, achieving high clearance rates of the pathogen from the gastric epithelium. While pharmacological therapy forms the cornerstone of treatment, tailored clinical dietetics and evidence-based phytotherapy play crucial roles in mucosal regeneration and symptom alleviation. During active gastroduodenal ulceration or acute inflammation, a bland, easily digestible diet devoid of mucosal irritants—such as pungent spices, excessive dietary acids, strong coffee, and alcohol—is mandatory. Concurrently, functional foods with proven gastroprotective and bacteriostatic efficacy should be incorporated: plant mucilages (flaxseed, marshmallow root, plantain extracts) that form a mechanical protective barrier over eroded tissues; sulforaphane derived from broccoli sprouts, which exerts potent bacteriostatic activity against H. pylori strains; cranberry proanthocyanidins that competitively inhibit bacterial adhesion to gastric mucosal cells; and targeted probiotics (such as Lactobacillus johnsonii LA1 and Saccharomyces boulardii) that significantly decrease antibiotic-related adverse events and accelerate microbial restoration.

Infection with *Helicobacter pylori* often necessitates a multifaceted therapeutic approach in which carefully selected medicinal herbs with documented antimicrobial properties can play a significant role. Botanical materials contain a diverse array of bioactive compounds—ranging from polyphenols and glycosides to essential oils—whose efficacy has been substantiated through *in vitro* and *in vivo* research. The systematic administration of appropriately formulated herbal preparations may not only accelerate pathogen eradication but also fortify the gastric mucosal barrier, thereby diminishing the likelihood of disease recurrence. It is crucial to emphasize, however, that herbal medicine should serve as a *complement* to, rather than a *replacement* for, the antibiotic regimens prescribed by healthcare professionals. Prior to integrating any dietary supplements into the treatment protocol, consultation with the attending physician is indispensable due to potential interactions between phytochemical constituents and synthetic active pharmaceutical ingredients.